Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness and Safety of Early Lumbar Drainage Plus Intrathecal Urokinase Injection in the Treatment of Severe Aneurysmal Subarachnoid Hemorrhage (LD-ITUK): a Multicentral Randomized Control Trial

NCT06284642 is registered in ClinicalTrials.gov with Second Affiliated Hospital of Nanchang University as lead sponsor.

NCT NCT06284642
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06284642 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness and Safety of Early Lumbar Drainage Plus Intrathecal Urokinase Injection in the Treatment of Severe Aneurysmal Subarachnoid Hemorrhage (LD-ITUK): a Multicentral Randomized Control Trial
Lead sponsor
Second Affiliated Hospital of Nanchang University
Phase
Phase 4
Overall status
Recruiting
Start date
March 28, 2024
Completion date
December 30, 2027
Enrollment
424 (estimated)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

aneurysmal subarachnoid hemorrhage